Literature DB >> 15670823

Bioluminescence resonance energy transfer identify scaffold protein CNK1 interactions in intact cells.

Marco A Lopez-Ilasaca1, Julio C Bernabe-Ortiz, Soon-Young Na, Victor J Dzau, Ramnik J Xavier.   

Abstract

Connector enhancer of KSR (CNK) proteins have been proposed to act as scaffolds in the Ras-MAPK pathway. In this work, using in vivo bioluminescence resonance energy transfer (BRET) assays and in vitro co-immunoprecipitation, we show that hCNK1 interacts with the active form of Rho A (G14V) proteins. The domain of hCNK1 that allows binding to Rho proteins involves the C-terminal PH domain. Overexpression of hCNK1 does not affect the actin cytoskeleton and does not modify the appearance of stress fibers in cells overexpressing a constitutively active form of RhoA. In contrast, hCNK1 was able to significantly decrease the RhoA-induced transcriptional activity of the serum response element (SRE) without effect on the Ras-induced SRE activation. These results identify hCNK1 as a specific partner of Rho proteins both in vitro and in vivo and suggest a role of hCNK1 in the signal transduction of Rho proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670823     DOI: 10.1016/j.febslet.2004.12.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  A molecular-properties-based approach to understanding PDZ domain proteins and PDZ ligands.

Authors:  Cosmas Giallourakis; Zhifang Cao; Todd Green; Heather Wachtel; Xiaohui Xie; Marco Lopez-Illasaca; Mark Daly; John Rioux; Ramnik Xavier
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

2.  Caenorhabditis elegans CNK-1 promotes Raf activation but is not essential for Ras/Raf signaling.

Authors:  Christian E Rocheleau; Agneta Rönnlund; Simon Tuck; Meera V Sundaram
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

3.  An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

Authors:  Martin Indarte; Roisin Puentes; Marco Maruggi; Nathan T Ihle; Geoffrey Grandjean; Michael Scott; Zamal Ahmed; Emmanuelle J Meuillet; Shuxing Zang; Robert Lemos; Lei Du-Cuny; Fabiana I A L Layng; Ricardo G Correa; Laurie A Bankston; Robert C Liddington; Lynn Kirkpatrick; Garth Powis
Journal:  Cancer Res       Date:  2019-04-30       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.